| Identification |
| Name: | Glycine,N-[(5Z,8Z,11Z,14Z)-1-oxo-5,8,11,14-eicosatetraen-1-yl]- |
| Synonyms: | Glycine,N-(1-oxo-5,8,11,14-eicosatetraenyl)-, (all-Z)-;Glycine,N-[(5Z,8Z,11Z,14Z)-1-oxo-5,8,11,14-eicosatetraenyl]- (9CI);N-Arachidonoylglycine; |
| CAS: | 179113-91-8 |
| Molecular Formula: | C22H35NO3 |
| Molecular Weight: | 361.52 |
| Molecular Structure: |
 |
| Properties |
| Density: | 0.985 g/cm3 |
| Solubility: | DMSO: >5 mg/mL, soluble |
| Biological Activity: | Endogenous anandamide-like compound. Lacks affinity for CB 1 receptors (K i > 10 μ M), VR1 receptors (EC 50 > 10 μ M) and anandamide transporters (IC 50 > 50 μ M) but causes hot-plate analgesia in mice when given orally, and suppresses tonic inflammatory pain. Also endogenous GlyT2 inhibitor. |
| Storage Temperature: | −20°C |
| Color: | off-white |
| Safety Data |
| |
 |
